Get the Stockscreener App
0.3289
4.17%
-0.0143
After Hours:
.33
0.0011
+0.33%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.3289, with a volume of 612.70K.
It is down -4.17% in the last 24 hours and down -29.43% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.3432
Open:
$0.3473
24h Volume:
612.70K
Relative Volume:
0.10
Market Cap:
$13.66M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-0.5221
EPS:
-0.63
Net Cash Flow:
$-13.77M
1W Performance:
-0.27%
1M Performance:
-29.43%
6M Performance:
-29.19%
1Y Performance:
-86.03%
1-Day Range:
$0.3276
$0.3473
1-Week Range:
$0.315
$0.3518
52-Week Range:
$0.2179
$3.00
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.3289 | 14.26M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
488.12 | 184.46B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.00 | 147.69B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.86 | 51.34B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.69 | 33.60B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
188.80 | 31.92B | 15.70B | 1.24B | 2.01B | 6.91 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
Intraday pattern recognizer results for ProPhase Labs Inc.July 2025 PostEarnings & Fast Entry Momentum Trade Alerts - Newser
Will ProPhase Labs Inc. benefit from macro trendsTrend Reversal & Risk Adjusted Buy/Sell Alerts - Newser
Published on: 2025-08-27 10:26:30 - Newser
Can a trend reversal in ProPhase Labs Inc. lead to recoveryWeekly Profit Analysis & Trade Opportunity Analysis Reports - Newser
Measuring ProPhase Labs Inc.’s beta against major indices2025 Short Interest & Verified Technical Signals - Newser
Does ProPhase Labs Inc. show high probability of reboundMarket Sentiment Review & Weekly Consistent Profit Watchlists - Newser
Is it too late to sell ProPhase Labs Inc.2025 Volume Leaders & Daily Risk Controlled Trade Plans - Newser
Technical signs of recovery in ProPhase Labs Inc.2025 Price Targets & Precise Trade Entry Recommendations - Newser
How to track smart money flows in ProPhase Labs Inc.CEO Change & AI Forecasted Entry/Exit Points - Newser
How to integrate ProPhase Labs Inc. into portfolio analysis tools2025 Market Outlook & Weekly High Momentum Picks - Newser
ProPhase Labs Inc. Inches Above Key Support — Safe to Hold getLinesFromResByArray error: size == 0 - 클래시안
What MACD and RSI say about ProPhase Labs Inc.Market Trend Report & Free Technical Confirmation Trade Alerts - Newser
Why ProPhase Labs Inc. stock attracts strong analyst attentionJuly 2025 Movers & Weekly High Return Opportunities - Newser
Is ProPhase Labs Inc. reversing from oversold territory2025 Major Catalysts & Target Return Focused Picks - Newser
Risk vs reward if holding onto ProPhase Labs Inc.Market Sentiment Report & Real-Time Market Sentiment Alerts - Newser
What earnings revisions data tells us about ProPhase Labs Inc.Index Update & AI Driven Price Forecasts - Newser
Real time scanner hits for ProPhase Labs Inc. explainedMarket Trend Summary & Entry Point Confirmation Alerts - Newser
ProPhase Labs Inc. Breakout Confirmed by Volume MetricsJuly 2025 Trade Ideas & Free Accurate Trade Setup Notifications - 더경남뉴스
Has ProPhase Labs Inc. found a price floorEarnings Miss & AI Forecast Swing Trade Picks - Newser
What’s the RSI of ProPhase Labs Inc. stockJuly 2025 Analyst Calls & Consistent Profit Trade Alerts - theviewers.co.kr
What makes ProPhase Labs Inc. stock price move sharply2025 Sector Review & Low Risk High Reward Ideas - Newser
Evaluating ProPhase Labs Inc. with trendline analysis2025 Stock Rankings & Long-Term Safe Investment Plans - Newser
ProPhase Labs Inc. Recovery Hinges on Volume BreakoutJuly 2025 Final Week & Community Supported Trade Ideas - 더경남뉴스
ProPhase Labs announces closing of $3M senior secured convertible notes - MSN
ProPhase Labs Receives SEC Approval for Special Meeting, Increases Authorized Shares to 1B - AInvest
ProPhase Labs, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:PRPH) - Seeking Alpha
ProPhase Labs Achieves Key U.S. Patent for Test - MSN
Strategies to average down on ProPhase Labs Inc.Trade Ideas & Free Safe Entry Trade Signal Reports - Newser
Prophase Labs Files Proxy, Reschedules Shareholder Meeting - TipRanks
ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders - GlobeNewswire
ProPhase Labs Announces New Date for Special Meeting of Shareholders. - AInvest
1 Billion Shares: ProPhase Labs Plans Major Expansion into Bitcoin Strategy and $15M Buyback Program - Stock Titan
Sentiment analysis tools applied to ProPhase Labs Inc.Weekly Market Summary & Advanced Technical Analysis Signals - Newser
Analyzing drawdowns of ProPhase Labs Inc. with statistical toolsInsider Buying & Real-Time Buy Signal Notifications - Newser
ProPhase Labs Inc (PRPH) Q2 2025 Earnings Call Highlights: Strategic Moves and Future Prospects - Yahoo Finance
ProPhase Labs Inc (PRPH) Q2 2025 Earnings Call Highlights: Strategic Moves and Future Prospects By GuruFocus - Investing.com Canada
Prophase Labs, Inc. shares fall 8.11% premarket as federal budget cuts and VC funding into oncology ventures. - AInvest
What is ProPhase Labs Inc. s revenue forecastJuly 2025 Intraday Action & Daily Market Momentum Tracking - 선데이타임즈
Why did PRPH's Q4 2024 earnings surprise analysts? - AInvest
Volume Surge May Signal Institutional Interest in ProPhase Labs Inc.Trade Risk Assessment & Free AI Powered Buy and Sell Recommendations - sundaytimes.kr
Can ProPhase Labs Inc. deliver alphaCPI Data & Precise Swing Trade Alerts - thegnnews.com
ProPhase Labs announces full USPTO approval for issuance of U.S. patent - MSN
Price Channel Expanding on ProPhase Labs Inc.’s ChartTrade Ideas & Daily Entry Point Trade Alerts - beatles.ru
Prophase Labs shares rise 2.14% intraday after earnings results presentation. - AInvest
ProPhase Labs 2025 Q2 Earnings Improved Losses Despite Revenue Decline - AInvest
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):